The test searches for DNA changes in the blood linked to cancer (Image: Getty) An “ultra-sensitive” blood test can predict which breast cancer survivors will relapse years before scans show evidence of tumours. In the earliest case, the blood test correctly flagged cancer recurrence three years and five months earlier. Experts hope the breakthrough could have a “transformative effect”, allowing women to start treatment before the disease becomes incurable.
The test uses whole genome sequencing to search for DNA mutations that indicate the cancer has returned. function loadOvpScript(){let el=document.createElement('script');el.
setAttribute('src','https://live.primis.tech/live/liveView.
php?s=114945&playerApiId=v114945');document.getElementById('ovp-primis').appendChild(el)}window.
top.addEventListener('primisPlayerInit',e=>{try{if(e.detail&&e.
detail.playerApiId==="v114945"){if(window.document.
getElementsByClassName('jwplayer')[0]){e.detail.float('disable')}}}catch(e){}});window.
addEventListener('DOMContentLoaded',()=>{setTimeout(()=>{if(typeof flagTcfLoaded!=='undefined'&&flagTcfLoaded===!0){loadOvpScript()ExpressApp.Log('[Load] OVP flagTcfLoaded',new Date())}else{document.addEventListener("tcfLoaded",()=>{loadOvpScript()ExpressApp.
Log('[Load] OVP tcfLoaded',new Date())})}},1500)}) In an early trial involving 74 women, it correctly identified all 11 who later relapsed. READ MORE: Breakthrough as simple at-home saliva test could ‘turn tide’ on prostate cancer The test.
